Coronary Guidewires Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

A coronary guidewire is used to navigate catheters during angiography and Percutaneous Coronary Interventions (PCIs). The guidewire has an elongated body which provides flexibility and a distal tip. Generally, a coronary guidewire has three parts: central core, outer covering and flexible distal tip. The core is made of either stainless steel, dura steel or nitinol. The coating on guidewire may be either hydrophilic or hydrophobic. GlobalData’s Medical Devices sector report, “Coronary Guidewires Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update” provides comprehensive information about the Coronary Guidewires pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Coronary Guidewires report provides key information and data related to:
Extensive coverage of the Coronary Guidewires under development
Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates
Reviews of major players involved in the pipeline product development.
Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and the number of trials of the major Coronary Guidewires pipeline products.
Review of Recent Developments in the segment / industry
The Coronary Guidewires report enables you to:
Access significant competitor information, analysis, and insights to improve your R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Coronary Guidewires under development
Formulate market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025
• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports
• 64,000+ medical equipment company profiles
• 5,600+ company profiles of medical equipment manufacturers in China and India
• 2,200+ company profiles of medical equipment manufacturers in Japan
• 1,200+ companies’ revenue splits and market shares
• 1,600+ quarterly and annual medical equipment company financials
• 850+ medical equipment company SWOTs
• 28,000+ pipeline product profiles
• 56,400+ marketed product profiles
• 47,000+ clinical trials
• 41,500+ trial investigators
• 7,000+ reports on companies with products in development
• 44,000+ deals in the medical equipment industry
• 1,100+ surgical and diagnostic procedures by therapy area
• 50+ key healthcare indicators by country
• 431,000+ Themes Content Items
• 600+ Influencers
• 1,900+ Analysts & Researchers
• 0.5m+ Community Members
• 141,000+ Macroeconomic Indicators
• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:
https://medical.globaldata.com/home.aspx
Custom Requirements
Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

– Extensive coverage of the Coronary Guidewires under development _x000D_

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities_x000D_

– The report reviews the major players involved in the development of Coronary Guidewires and list all their pipeline projects_x000D_

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage_x000D_

– The report provides key clinical trial data of ongoing trials specific to pipeline products_x000D_

– Recent developments in the segment / industry

Reasons to Buy

The report enables you to – _x000D_

– Formulate significant competitor information, analysis, and insights to improve R&D strategies_x000D_

– Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage_x000D_

– Identify and understand important and diverse types of Coronary Guidewires under development_x000D_

– Develop market-entry and market expansion strategies_x000D_

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline_x000D_

– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Abbott Vascular Inc
AdenoPaint LLC
APT Medical Inc
Bioscan Technologies Inc.
Boston Scientific Corp
Cardiovascular Systems Inc
CorMetrics LLC
Echopoint Medical Ltd
ENDOMATERIALS
Georgia Institute of Technology
Guided Interventions, LLC
Infrared Sciences Corp
Koninklijke Philips NV
Microbot Medical Ltd
MicroPort Scientific Corp
NewMed Medical Co Ltd
Nirtek Pty Ltd
Opsens Inc
OVALUM Ltd
SoundBite Medical Solutions Inc
St. Jude Medical LLC
Terumo Corp
Terumo Interventional Systems
The Cleveland Clinic Foundation
Three Rivers Cardiovascular Systems Inc
Transmural systems LLC
University of Illinois at Chicago
Vasostar Ltd.
Xenter Inc

Table of Contents

1 Table of Contents 3

1.1 List of Tables 6

1.2 List of Figures 9

2 Introduction 10

2.1 Coronary Guidewires Overview 10

3 Products under Development 11

3.1 Coronary Guidewires – Pipeline Products by Stage of Development 11

3.2 Coronary Guidewires – Pipeline Products by Territory 12

3.3 Coronary Guidewires – Pipeline Products by Regulatory Path 13

3.4 Coronary Guidewires – Pipeline Products by Estimated Approval Date 14

3.5 Coronary Guidewires – Ongoing Clinical Trials 15

4 Coronary Guidewires – Pipeline Products under Development by Companies 16

4.1 Coronary Guidewires Companies – Pipeline Products by Stage of Development 16

4.2 Coronary Guidewires – Pipeline Products by Stage of Development 18

5 Coronary Guidewires Companies and Product Overview 19

5.1 Abbott Vascular Inc Company Overview 19

5.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 19

5.2 AdenoPaint LLC Company Overview 20

5.2.1 AdenoPaint LLC Pipeline Products & Ongoing Clinical Trials Overview 20

5.3 APT Medical Inc Company Overview 21

5.3.1 APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 21

5.4 Bioscan Technologies Inc. Company Overview 23

5.4.1 Bioscan Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 23

5.5 Boston Scientific Corp Company Overview 24

5.5.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 24

5.6 Cardiovascular Systems Inc Company Overview 26

5.6.1 Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 26

5.7 CorMetrics LLC Company Overview 27

5.7.1 CorMetrics LLC Pipeline Products & Ongoing Clinical Trials Overview 27

5.8 Echopoint Medical Ltd Company Overview 28

5.8.1 Echopoint Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 28

5.9 ENDOMATERIALS Company Overview 29

5.9.1 ENDOMATERIALS Pipeline Products & Ongoing Clinical Trials Overview 29

5.10 Georgia Institute of Technology Company Overview 30

5.10.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 30

5.11 Guided Interventions, LLC Company Overview 31

5.11.1 Guided Interventions, LLC Pipeline Products & Ongoing Clinical Trials Overview 31

5.12 Infrared Sciences Corp Company Overview 32

5.12.1 Infrared Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview 32

5.13 Koninklijke Philips NV Company Overview 33

5.13.1 Koninklijke Philips NV Pipeline Products & Ongoing Clinical Trials Overview 33

5.14 Microbot Medical Ltd Company Overview 34

5.14.1 Microbot Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 34

5.15 MicroPort Scientific Corp Company Overview 35

5.15.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 35

5.16 NewMed Medical Co Ltd Company Overview 37

5.16.1 NewMed Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 37

5.17 Nirtek Pty Ltd Company Overview 38

5.17.1 Nirtek Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 38

5.18 Opsens Inc Company Overview 39

5.18.1 Opsens Inc Pipeline Products & Ongoing Clinical Trials Overview 39

5.19 OVALUM Ltd Company Overview 42

5.19.1 OVALUM Ltd Pipeline Products & Ongoing Clinical Trials Overview 42

5.20 SoundBite Medical Solutions Inc Company Overview 43

5.20.1 SoundBite Medical Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 43

5.21 St. Jude Medical LLC Company Overview 44

5.21.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 44

5.22 Terumo Corp Company Overview 45

5.22.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 45

5.23 Terumo Interventional Systems Company Overview 46

5.23.1 Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview 46

5.24 The Cleveland Clinic Foundation Company Overview 47

5.24.1 The Cleveland Clinic Foundation Pipeline Products & Ongoing Clinical Trials Overview 47

5.25 Three Rivers Cardiovascular Systems Inc Company Overview 48

5.25.1 Three Rivers Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 48

5.26 Transmural systems LLC Company Overview 49

5.26.1 Transmural systems LLC Pipeline Products & Ongoing Clinical Trials Overview 49

5.27 University of Illinois at Chicago Company Overview 52

5.27.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 52

5.28 Vasostar Ltd. Company Overview 53

5.28.1 Vasostar Ltd. Pipeline Products & Ongoing Clinical Trials Overview 53

5.29 Xenter Inc Company Overview 56

5.29.1 Xenter Inc Pipeline Products & Ongoing Clinical Trials Overview 56

6 Coronary Guidewires- Recent Developments 57

6.1 Apr 04, 2024: AngioDynamics Reports Results for the Quarter Ended In February 57

6.2 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference 57

6.3 Feb 28, 2024: Merit Medical Introduces ‘Continued Growth Initiatives’ Program and Financial Targets for Three-Year Period Ending December 31, 2026 57

6.4 Feb 28, 2024: Boston Scientific Raises $2.2B to Support Purchase of California Medical Device Company 57

6.5 Feb 23, 2024: Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering 58

6.6 Feb 19, 2024: Boston Scientific Appoints Madan Krishnan to Lead India Subcontinent 58

6.7 Feb 07, 2024: Terumo Announces Change of Executive Officers (PDF

232.27 KB) 58

6.8 Jan 31, 2024: Boston Scientific Announces Results for Fourth Quarter and Full Year 2023 58

6.9 Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results 60

6.10 Jan 05, 2024: AngioDynamics Reports Fiscal Year 2024 Second Quarter Financial Results; Revises Fiscal Year 2024 Guidance 60

6.11 Dec 18, 2023: Merit Medical Announces Process for Chief Executive Officer Succession Planning 62

6.12 Nov 10, 2023: Microport Appointment of Director 62

6.13 Oct 26, 2023: Boston Scientific Announces Results for Third Quarter 2023 63

6.14 Oct 23, 2023: OPSENS Announces the Positive Clinical Results from the SAFE-TAVI Study with Savvywire in Europe 65

6.15 Oct 18, 2023: Abbott Reports Third-Quarter 2023 Results and Raises Midpoint of Full-Year EPS Guidance Range 66

6.16 Oct 17, 2023: Opsens to Participate in the Transcatheter Cardiovascular Therapeutics Conference (TCT) In San Francisco October 23 – 26, 2023 68

6.17 Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business 68

6.18 Sep 29, 2023: Barry Slowey Named Vice President and Chief Sustainability Officer 69

6.19 Sep 21, 2023: Microport Scientific Corp. Announces 2023 Interim Report 69

6.20 Sep 15, 2023: Amber Beauchamp Named Vice President of Global Human Resources 71

6.21 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair 72

6.22 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024 72

6.23 Aug 07, 2023: Cleveland Clinic Appoints Albert Marinez as its First Chief Analytics Officer 72

6.24 Jul 19, 2023: Boston Scientific lays off 52 workers as it closes another Silicon Valley facility 72

6.25 Jul 11, 2023: Microport Scientific Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023 73

6.26 Jun 12, 2023: Abbott Names Philip Boudreau CFO effective Sept. 1 73

6.27 May 15, 2023: Asahi Intecc Co. announces consolidated financial results for the nine months ended March 31, 2023 73

6.28 May 15, 2023: Terumo announces consolidated financial results for the fiscal year ended March 31, 2023 73

6.29 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023 73

6.30 May 10, 2023: Opsens announces inclusion of Savvywire in complete TAVR study 74

7 Appendix 75

7.1 Methodology 75

7.2 About GlobalData 78

7.3 Contact Us 78

7.4 Disclaimer 78

Table

Coronary Guidewires – Pipeline Products by Stage of Development 11

Coronary Guidewires – Pipeline Products by Territory 12

Coronary Guidewires – Pipeline Products by Regulatory Path 13

Coronary Guidewires – Pipeline Products by Estimated Approval Date 14

Coronary Guidewires – Ongoing Clinical Trials 15

Coronary Guidewires Companies – Pipeline Products by Stage of Development 16

Coronary Guidewires – Pipeline Products by Stage of Development 18

Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 19

Hi-Torque Vector – Product Status 19

Hi-Torque Vector – Product Description 19

AdenoPaint LLC Pipeline Products & Ongoing Clinical Trials Overview 20

Adenowire – Product Status 20

Adenowire – Product Description 20

APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 21

SCG Guidewire – Product Status 21

SCG Guidewire – Product Description 21

WCG Guidewire – Product Status 22

WCG Guidewire – Product Description 22

Bioscan Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 23

Lightwire – Product Status 23

Lightwire – Product Description 23

Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 24

Crossing Wire – Product Status 24

Crossing Wire – Product Description 24

Rotawire Drive – Product Status 25

Rotawire Drive – Product Description 25

Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 26

ZILIENT Guidewire – Coronary Intervention – Product Status 26

ZILIENT Guidewire – Coronary Intervention – Product Description 26

CorMetrics LLC Pipeline Products & Ongoing Clinical Trials Overview 27

Fractional Flow Reserve Guide Wire System – Product Status 27

Fractional Flow Reserve Guide Wire System – Product Description 27

Echopoint Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 28

iKOs Guidewire – Coronary Intervention – Product Status 28

iKOs Guidewire – Coronary Intervention – Product Description 28

ENDOMATERIALS Pipeline Products & Ongoing Clinical Trials Overview 29

Multimodal Sensing Guidewire – Product Status 29

Multimodal Sensing Guidewire – Product Description 29

Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 30

Intravascular Ultrasound Imaging Guidewire – Product Status 30

Intravascular Ultrasound Imaging Guidewire – Product Description 30

Guided Interventions, LLC Pipeline Products & Ongoing Clinical Trials Overview 31

Pressure Sensing Coronary Artery Guide Wire – Product Status 31

Pressure Sensing Coronary Artery Guide Wire – Product Description 31

Infrared Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview 32

Steerable Guidewire – Product Status 32

Steerable Guidewire – Product Description 32

Koninklijke Philips NV Pipeline Products & Ongoing Clinical Trials Overview 33

ComboWire Plus Pressure And Flow Wire – Product Status 33

ComboWire Plus Pressure And Flow Wire – Product Description 33

Microbot Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 34

CardioSert – Double Concentric Guidewire – Product Status 34

CardioSert – Double Concentric Guidewire – Product Description 34

MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 35

Micro-Guide Wire – Product Status 35

Micro-Guide Wire – Product Description 35

Pressure Guidewire – Product Status 36

Pressure Guidewire – Product Description 36

NewMed Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 37

Guide Wire – Product Status 37

Guide Wire – Product Description 37

Nirtek Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 38

NIRAF Guidewire – Product Status 38

NIRAF Guidewire – Product Description 38

Opsens Inc Pipeline Products & Ongoing Clinical Trials Overview 39

SavvyWire – Product Status 39

SavvyWire – Product Description 39

Opsens Inc – Ongoing Clinical Trials Overview 40

SavvyWire – A Randomized, Comparative Effectiveness Study of Staged Complete Revascularization With Percutaneous Coronary Intervention to Treat Coronary Artery Disease vs Medical Management Alone in Patients with Symptomatic Aortic Valve Stenosis Undergoing Elective Transfemoral Transcatheter Aortic Valve Replacement: The COMPLETE TAVR Study 41

SavvyWire – Evaluation of the Aortic Regurgitation Index (ARi) Measured With the Opsens SavvyWire to Determine the Correlation Between Regurgitation Evaluation Using Echography and Aortography 41

OVALUM Ltd Pipeline Products & Ongoing Clinical Trials Overview 42

OctoBooster Extension Guidewire – Product Status 42

OctoBooster Extension Guidewire – Product Description 42

SoundBite Medical Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 43

SoundBite Active Wire – Coronary – Product Status 43

SoundBite Active Wire – Coronary – Product Description 43

St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 44

Sensor Enabled – Quadra Excel Guidewire – Product Status 44

Sensor Enabled – Quadra Excel Guidewire – Product Description 44

Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 45

Izanai – Product Status 45

Izanai – Product Description 45

Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview 46

Wrist Artery Guidewire – Product Status 46

Wrist Artery Guidewire – Product Description 46

The Cleveland Clinic Foundation Pipeline Products & Ongoing Clinical Trials Overview 47

CTO Guidewire – Product Status 47

CTO Guidewire – Product Description 47

Three Rivers Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 48

SmartGuidewire – Product Status 48

SmartGuidewire – Product Description 48

Transmural systems LLC Pipeline Products & Ongoing Clinical Trials Overview 49

TELLTALE Electrosurgical Guidewire System – Product Status 49

TELLTALE Electrosurgical Guidewire System – Product Description 49

Transmural systems LLC – Ongoing Clinical Trials Overview 50

TELLTALE Electrosurgical Guidewire System – NHLBI Transmural Electrosurgery LeafLet Traversal and Laceration Evaluation (TELLTALE) BASILICA-TAVR Trial 51

University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 52

CTO Wire – Product Status 52

CTO Wire – Product Description 52

Vasostar Ltd. Pipeline Products & Ongoing Clinical Trials Overview 53

VasoStar Vibrational Guidewire System – Product Status 53

VasoStar Vibrational Guidewire System – Product Description 53

Vasostar Ltd. – Ongoing Clinical Trials Overview 54

VasoStar Vibrational Guidewire System – Evaluation of a Vibrational Guidewire System to Facilitate Crossing Coronary Artery Chronic Total Occlusions in Patients With Chronic Angina Refractory to Maximally Tolerated Guideline Directed Medical Therapy 55

Xenter Inc Pipeline Products & Ongoing Clinical Trials Overview 56

TAVR SmartWire – Product Status 56

TAVR SmartWire – Product Description 56

Glossary 77

Figures

Coronary Guidewires – Pipeline Products by Stage of Development 10

Coronary Guidewires – Pipeline Products by Territory 11

Coronary Guidewires – Pipeline Products by Regulatory Path 12

Coronary Guidewires – Pipeline Products by Estimated Approval Date 13

Coronary Guidewires – Ongoing Clinical Trials 14

Frequently asked questions

Coronary Guidewires Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Coronary Guidewires Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Coronary Guidewires Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Coronary Guidewires Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.